1. Home
  2. ENSC vs AUID Comparison

ENSC vs AUID Comparison

Compare ENSC & AUID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ensysce Biosciences Inc.

ENSC

Ensysce Biosciences Inc.

SELL

Current Price

$0.56

Market Cap

7.6M

Sector

Health Care

ML Signal

SELL

Logo authID Inc.

AUID

authID Inc.

HOLD

Current Price

$0.32

Market Cap

7.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENSC
AUID
Founded
2003
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
7.6M
7.3M
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
ENSC
AUID
Price
$0.56
$0.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 464.1K
425.8K
Earning Date
11-13-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 65.24
60.00
EPS
N/A
★ N/A
Revenue
★ $5,066,650.00
$2,040,660.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 130.20
52 Week Low
$0.23
$0.32
52 Week High
$2.75
$2.97

Technical Indicators

Market Signals
Indicator
ENSC
AUID
Relative Strength Index (RSI) 73.13 40.93
Support Level $0.47 N/A
Resistance Level $0.61 $0.59
Average True Range (ATR) 0.04 0.07
MACD 0.01 -0.00
Stochastic Oscillator 91.64 7.15

Price Performance

Historical Comparison
ENSC
AUID

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About AUID authID Inc.

AuthID Inc is a company engaged in ensuring enterprises - Know Who's Behind the Device, for every customer or employee login and transaction, through its easy-to-integrate, patented, biometric identity platform. authID powers biometric identity proofing, biometric authentication, and account recovery with a fast, accurate, user-friendly experience. With its PrivacyKey solution, authID provides accurate biometric authentication while storing no biometric data. authID's goal is to stop fraud at onboarding, blocks deepfakes, prevents account takeover, and eliminates password risks and costs, through the faster, and accurate user identity experience demanded by the digital ecosystem Its products are: IDX Mandate for Agentic AI, PrivacyKey, Identity Verification, and Biometric Authentication.

Share on Social Networks: